Physician

Sumeet Thareja, MD

According to 2025 Medicare claims, Sumeet Thareja, MD (NPI: 1609165794) practices dermatology in the Palm Bay-Melbourne-Titusville, FL market, with the plurality of this provider's patient population coming from Brevard, FL. This provider's primary affiliated billing organization is INDIGO DERMATOLOGY LLC (NPI: 1659743094; TIN: 475068597) and primary practice location at 32901-1459.

Thareja's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 352 traditional Medicare patients, billed 8,310 HCPCS/CPT codes, and received $4,147,807 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 960 prescription claims across 336 beneficiaries totaling $192,219 in drug costs, led by Otezla (Apremilast). Open Payments data shows 9 records totaling $165. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $177,409 to $4,147,807. Similarly, Part D prescription costs have moved sharply higher in recent years, from $6,539 to $192,219. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.1M$4.2M2016 Medicare payment: $177,409 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $184,546 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $399,043 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $412,588 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $321,113 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,392,915 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,962,990 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,200,624 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,147,807 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
20162862,543$177,409
20172732,092$184,546
20184849,124$399,043
201951210,744$412,588
20202788,786$321,113
202125310,359$1,392,915
202231012,288$2,962,990
20232768,184$4,200,624
20243528,310$4,147,807

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$120K$241K2015 Drug cost: $6,539 (USD; Tot_Drug_Cst)2016 Drug cost: $9,941 (USD; Tot_Drug_Cst)2017 Drug cost: $30,642 (USD; Tot_Drug_Cst)2018 Drug cost: $43,244 (USD; Tot_Drug_Cst)2019 Drug cost: $82,447 (USD; Tot_Drug_Cst)2020 Drug cost: $43,546 (USD; Tot_Drug_Cst)2021 Drug cost: $47,206 (USD; Tot_Drug_Cst)2022 Drug cost: $240,919 (USD; Tot_Drug_Cst)2023 Drug cost: $146,668 (USD; Tot_Drug_Cst)2024 Drug cost: $192,219 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152940$6,539
2016135232$9,941
2017165335$30,642
2018242578$43,244
2019221519$82,447
2020186475$43,546
2021201600$47,206
2022236682$240,919
2023281740$146,668
2024336960$192,219

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more169269$94
17110Destruction of skin growth, 1-14 growths91126$78
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more186355$67
11102Biopsy of related skin growth, first growth107134$61
17000Destruction of precancer skin growth, 1 growth126176$38

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OtezlaApremilast27810$124,926
Clobetasol PropionateClobetasol Propionate1003,252$4,118
FluorouracilFluorouracil391,020$3,323
KetoconazoleKetoconazole1574,188$2,302
MetronidazoleMetronidazole331,115$2,134

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.9$165Smith+Nephew, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Sumeet Thareja, MD?

Tedicare shows public-source Medicare data for Sumeet Thareja, MD (NPI 1609165794), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sumeet Thareja, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sumeet Thareja, MD?

Sumeet Thareja, MD is linked to INDIGO DERMATOLOGY LLC (billing NPI 1659743094) in the available physician profile data.

Does Sumeet Thareja, MD have Open Payments data?

Sumeet Thareja, MD has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.